ArticleJournal of molecular histology2025

TAK-242 inhibits toll-like receptor-4 signaling and attenuates cancer-associated muscle atrophy via the p38-C/EBPβ pathway.

Yongfei You et al.PubMed ↗Publisher ↗

No numbers read from the abstract.